Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Inventory: 2023-2024

Historic Inventory for Krystal Biotech (KRYS) over the last 2 years, with Dec 2024 value amounting to $26.5 million.

  • Krystal Biotech's Inventory rose 102.53% to $37.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.6 million, marking a year-over-year increase of 102.53%. This contributed to the annual value of $26.5 million for FY2024, which is 279.50% up from last year.
  • Latest data reveals that Krystal Biotech reported Inventory of $26.5 million as of FY2024, which was up 279.50% from $7.0 million recorded in FY2023.
  • Krystal Biotech's Inventory's 5-year high stood at $26.5 million during FY2024, with a 5-year trough of $7.0 million in FY2023.
  • In the last 2 years, Krystal Biotech's Inventory had a median value of $16.7 million in 2023 and averaged $16.7 million.
  • Data for Krystal Biotech's Inventory shows a peak YoY skyrocketed of 279.50% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Krystal Biotech's Inventory stood at $7.0 million in 2023, then skyrocketed by 279.50% to $26.5 million in 2024.